Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: results of a phase III randomized trial.
Janssens GO, Rademakers SE, Terhaard CH, Doornaert PA, Bijl HP, van den Ende P, Chin A, Marres HA, de Bree R, van der Kogel AJ, Hoogsteen IJ, Bussink J, Span PN, Kaanders JH. Janssens GO, et al. Among authors: hoogsteen ij. J Clin Oncol. 2012 May 20;30(15):1777-83. doi: 10.1200/JCO.2011.35.9315. Epub 2012 Apr 16. J Clin Oncol. 2012. PMID: 22508814 Clinical Trial.
Pattern of CAIX expression is prognostic for outcome and predicts response to ARCON in patients with laryngeal cancer treated in a phase III randomized trial.
Rademakers SE, Hoogsteen IJ, Rijken PF, Oosterwijk E, Terhaard CH, Doornaert PA, Langendijk JA, van den Ende P, Takes R, De Bree R, van der Kogel AJ, Bussink J, Kaanders JH. Rademakers SE, et al. Among authors: hoogsteen ij. Radiother Oncol. 2013 Sep;108(3):517-22. doi: 10.1016/j.radonc.2013.04.022. Epub 2013 May 26. Radiother Oncol. 2013. PMID: 23719582 Clinical Trial.
Prognostic value of the proliferation marker Ki-67 in laryngeal carcinoma: results of the accelerated radiotherapy with carbogen breathing and nicotinamide phase III randomized trial.
Rademakers SE, Hoogsteen IJ, Rijken PF, Terhaard CH, Doornaert PA, Langendijk JA, van den Ende P, van der Kogel AJ, Bussink J, Kaanders JH. Rademakers SE, et al. Among authors: hoogsteen ij. Head Neck. 2015 Feb;37(2):171-6. doi: 10.1002/hed.23569. Epub 2014 Feb 12. Head Neck. 2015. PMID: 24347430 Clinical Trial.
Improved recurrence-free survival with ARCON for anemic patients with laryngeal cancer.
Janssens GO, Rademakers SE, Terhaard CH, Doornaert PA, Bijl HP, van den Ende P, Chin A, Takes RP, de Bree R, Hoogsteen IJ, Bussink J, Span PN, Kaanders JH. Janssens GO, et al. Among authors: hoogsteen ij. Clin Cancer Res. 2014 Mar 1;20(5):1345-54. doi: 10.1158/1078-0432.CCR-13-1730. Epub 2014 Jan 22. Clin Cancer Res. 2014. PMID: 24452791 Free article. Clinical Trial.
16 results